US Patent Issued to SymbioCellTech on Oct. 6 for "Neo-Islets comprising stem and islet cells and treatment of diabetes mellitus therewith" (Utah Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,392, issued on Oct. 6, was assigned to SymbioCellTech LLC (Salt Lake City).

"Neo-Islets comprising stem and islet cells and treatment of diabetes mellitus therewith" was invented by Christof Westenfelder (Salt Lake City), Anna Gooch (Salt Lake City), Ping Zhang (Salt Lake City) and Zhuma Hu (Salt Lake City).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described are Neo-Islets comprising: a) dedifferentiated islet cells and mesenchymal and/or adipose stem cells; or b) redifferentiated islet cells and mesenchymal and/or adipose stem cells where the cells have been treated so as to facilitate redifferentiation. Further described herein are methods of g...